Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: J Pain Symptom Manage. 2013 Sep 7;47(2):218–230. doi: 10.1016/j.jpainsymman.2013.04.005

Table 5.

Outcomes Over Time by Treatment Group Adjusting for Baseline Value of Outcome and Current Chemotherapy

Symptom Outcomes Summary Statisticsa Differences Between Groups Repeated Measures Results

T2
Mean (SE)
T3
Mean (SE)
T2
Mean (SE)
t-value(df)
P-value
T3
Mean (SE)
t-value(df)
P-value
F-value (n,df)
P-value

Severity FGroup(1, 31.1)=1.50
P=0.229
  WRITE Symptoms 4.67 (0.43) 4.58 (0.58) −0.94 (0.48)
t(40.4)=−1.95
P=0.058
−0.31 (0.64)
t(47.3)=−0.49
P=0.626
FTime(1,50.1)=2.77
P=0.102
FG×T(1, 49.6)=1.72
  Control Group 5.61 (0.22) 4.80 (0.27) P=0.196

Distress FGroup(1, 56.7)=4.59
P=0.037
  WRITE Symptoms 1.41 (0.13) 1.42 (0.13) −0.45 (0.17)
t(88.4)=−2.57
P=0.012
−0.186 (0.17)
t(87.8)=−1.09
P=0.281
FTime(1,55)=1.69
P=0.199
FG×T(1,54.1)=2.18
  Control Group 1.85 (0.11) 1.61 (0.11) P=0.146

Consequences FGroup(1,57.4) =0.92
P=0.343
  WRITE Symptoms 1.77 (0.10) 1.76 (0.10) −0.164 (0.14)
t(87.6)=−1.17
P=0.244
−0.180 (0.14)
t(87.2)=−1.31
P=0.194
FTime(1,55.3)=0.86
P=0.357
FG×T(1,54.4)=0.51
  Control Group 1.94 (0.09) 1.82 (0.09) P=0.480

Controllability FGroup(1, 50.8)=0.18
P=0.673
  WRITE Symptoms 2.19 (0.11) 2.11 (0.10) 0.120 (0.14)
t(87.3)=0.84
P=0.404
−0.018 (0.14)
t(86.7)=−0.13
P=0.898
FTime(1, 49.5)=0.02
P=0.891
FG×T(1,48.6)=0.84
  Control Group 2.17 (0.09) 2.13(0.09) P=0.365
a

Values in cells are reported as least squares mean (standard error for mean) based on a linear mixed model adjusted for baseline level of outcome and whether on current chemotherapy.